Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

NCT00730769 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

DRUG: Single arm (ganciclovir and valganciclovir)

Sponsor

Salvador Gil-Vernet

Collaborators

[object Object]